{"name":"LigaChem Biosciences, Inc.","slug":"ligachem-biosciences-inc","ticker":"","exchange":"","domain":"ligachem.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LCB01-0371 800mg, BID","genericName":"LCB01-0371 800mg, BID","slug":"lcb01-0371-800mg-bid","indication":"Acute myeloid leukemia (AML)","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Bedaquiline, Delamanid, Moxifloxacin","genericName":"Bedaquiline, Delamanid, Moxifloxacin","slug":"bedaquiline-delamanid-moxifloxacin","indication":"Multidrug-resistant tuberculosis","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"LCB01-0371","genericName":"LCB01-0371","slug":"lcb01-0371","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"LCB01-0371 800mg, BID","genericName":"LCB01-0371 800mg, BID","slug":"lcb01-0371-800mg-bid","phase":"phase_2","mechanism":"LCB01-0371 is a selective inhibitor of lysine-specific demethylase 1 (LSD1) that restores gene expression silenced by aberrant histone methylation in cancer cells.","indications":["Acute myeloid leukemia (AML)","Myelodysplastic syndrome (MDS)"],"catalyst":""},{"name":"Bedaquiline, Delamanid, Moxifloxacin","genericName":"Bedaquiline, Delamanid, Moxifloxacin","slug":"bedaquiline-delamanid-moxifloxacin","phase":"phase_2","mechanism":"Inhibits Mycobacterium tuberculosis ATP synthase","indications":["Multidrug-resistant tuberculosis"],"catalyst":""},{"name":"LCB01-0371","genericName":"LCB01-0371","slug":"lcb01-0371","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5SOWZPMmNkVERzek4td1JwQ2FBNGtLNk94dU9tRXlhQ3VEZDFxa05FNUFLV0hiSnh4YUUtb1I1bmtFWnVBUkxfSExHTEE4cGhpTm9SVHdDcFRHQ3A0MEhtS3JscHJwX3pZTW11NU5B0gFyQVVfeXFMUFpyREVkb0VQbVRCSUlPMm1ZYUFVY0lXWDZ6NmgzbWVKMDB5WE5ZaVdRWWN2OHhDRVlKaVAySGdTWXpYMDZfT01yZENFSnp6alQ3NlR3VU9uT2lCdS04NVRsSFZ5bWFmd2hBMzF1eDlsNndn?oc=5","date":"2026-02-27","type":"deal","source":"koreabiomed.com","summary":"LigaChem secures additional milestone payment from Ono Pharma for ADC collaboration - koreabiomed.com","headline":"LigaChem secures additional milestone payment from Ono Pharma for ADC collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1WNVkteFZjY2IwUlczQUI3U2lSeElVUUxXTE9HX1pTNkR6STlMOFRGUmZlRXNqdFctZVFWY0tGN2VtUTJSb0JUQmxCcTZuRUZzVUdTbHRQR0VuWnY4bVI1NmFDQ3F4b3U1QUFvdWZR?oc=5","date":"2026-02-24","type":"deal","source":"koreabiomed.com","summary":"LigaChem strengthens ADC pipeline with new NovaRock licensing deal - koreabiomed.com","headline":"LigaChem strengthens ADC pipeline with new NovaRock licensing deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPNDRBRWRvZDJmM3dSRGE1SUxuUDBXcUVQNmdoYlM4M0ZaNjM2TGVxdnE5U2poYXFfSFNWQ1duNWdHR0lhV25teFNoMkdKWkh0ZFJOaHN4Qzc2SHZVbDFfT0hMN1RaNi1JclJXWGJfWG41VDBOdlU0Z0pSUVktVnFaTtIBlAFBVV95cUxPSDVrRVVlM1hFVWZlU2RFY1JTTHd2UGtfamRZMjdyQTY0aDFOOHJseVpfQ3liMVRmVWdmbW1qbWJkaFktS01fSnh6NUJ0Q29DeVFGLUJ6algxV0p4SlppTHE3ajBoekl2YmJ0S2d2MEY2STRZU1hoaHd2SUM1OGpFQ0NwVlJmV09RYlh2aXZyTUduQ1d3?oc=5","date":"2026-01-06","type":"deal","source":"Chosunbiz","summary":"LigaChem Biosciences seeks global partnerships at JPM 2026 to accelerate ADC technology transfer - CHOSUNBIZ - Chosunbiz","headline":"LigaChem Biosciences seeks global partnerships at JPM 2026 to accelerate ADC technology transfer - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE50dlMwbjQ4N0ZzbUNwYWRKYktXTUhPRWZJYUo3WkJRTmpvY0txSkpOZEZ2U0ZUVUFFMVRVbTlMQzViQXluVmR5NFFzMHpUSTdjck91YndvSW4tT2gtSXRVSHN6ajJIZ2hBX0d5MmFB0gFyQVVfeXFMTUhYbVZydG12Qm1NdmxyV1ZHQXZQRldlTWU3OTZUMkdaVFpOXzgxOVNIVi02cjc3Zms1RFZFQ3ltSFFFV0NIM3ZRVmVzZ3VUOHdXaE0zTDNBRWZmd1NVWmJFXzV4a21SS3NLTG1MT1N1bU5B?oc=5","date":"2026-01-06","type":"pipeline","source":"koreabiomed.com","summary":"[Analysis] LigaChem overhauls R&D to move beyond ADC platform era - koreabiomed.com","headline":"[Analysis] LigaChem overhauls R&D to move beyond ADC platform era","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-15","type":"pipeline","source":"simplywall.st","summary":"After Leaping 32% LigaChem Biosciences Inc. (KOSDAQ:141080) Shares Are Not Flying Under The Radar - simplywall.st","headline":"After Leaping 32% LigaChem Biosciences Inc. (KOSDAQ:141080) Shares Are Not Flying Under The Radar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVGhudTlQdmVrczBXOEY2Z3pDTmNKSWhVNXZvM3Jka1Y3VkhKMFdZYzIyaE9fb240SklNeVhWWWppRFhERWNOZ0FSQ2d6eU9zc2JaWmdqMWdkc1Nub1pXOHk5dkpGNk1kcXJkbjJBVzZGS041dkg1ODJsYUxCOGE2bkMzMzF2RUgyTlFsZXQtOFU2VFdPenk4dzBYQ0FoVl9wWnhMT1RZSm8zZw?oc=5","date":"2025-06-10","type":"deal","source":"BioWorld News","summary":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock - BioWorld News","headline":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1fSlJ2bWVNLXVsVWxqLU00aWdqOVhwQ1NkZ00ydlozZm8wV1had3VONHlOWVJqQ0tmWERPS1BHUkNtOUxQSXljeEVyYWlVV1EyTGd0bEJDWVEzaEU4SG9nTHVkUDFRb0d2TEdrZjF3?oc=5","date":"2025-05-22","type":"patent","source":"KED Global","summary":"Samsung Biologics to spin off biosimilar unit Samsung Bioepis - KED Global","headline":"Samsung Biologics to spin off biosimilar unit Samsung Bioepis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNUTNQMzFvWXEtWlkwR0Vjelk4dXJ1UmlCa0ZmUGVCdW0xdEMwQnF0MmdjQjR2a2Vsa2Q2ZGFoTGt0WkoxdDNmdTFPbk1Xbno1OFFJNlhveU4wZDRfcGJxcTlaY3Y0YlpPM1dvaGpYdUt4LTZaUnlnbWVHRGtyX0J2X3FRTG5sUXNVb0JMZ1AzdTdxZ3dYc1FqSDZJVDktdnRDZG9pZDAxVWpLUUx1c2pFdzh4MXk5OU0?oc=5","date":"2025-04-22","type":"deal","source":"The Pharma Letter","summary":"1ST Biotherapeutics and LigaChem form ADC partnership - The Pharma Letter","headline":"1ST Biotherapeutics and LigaChem form ADC partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9MNHloOUxWeFZpQUl5Wm9hcXVoMFdmXzJLTlNjLW9JeGFzMWY3bWJ5NEVJbnlOc0h4X1ZhY3Q5QmhYQk1ZTUVEZUNzdVJ4dmloeHJQMktjaVFfNkw1S0szYUhBZ1RjeWhKeFdVYkJB?oc=5","date":"2025-01-09","type":"deal","source":"KED Global","summary":"Samsung Biologics signs initial deal with LigaChem Bio on ADC production - KED Global","headline":"Samsung Biologics signs initial deal with LigaChem Bio on ADC production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE90S0w0VjlKRnN5amZJSzA2WGxjREdUNTRsMFRKWHlTQ3JrTFdwUUdfNUxDSXVuVjNJVUVUdXNLb3lwQnVrcnpGcmFTVFptRmlOS21XX2xFd1FKSkZtajFvbm9R?oc=5","date":"2024-10-12","type":"pipeline","source":"The Pharma Letter","summary":"LigaChem Biosciences - The Pharma Letter","headline":"LigaChem Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNWWFIOGdyaFdMNnBibDlVam5SMjhBUGtkQWtJUWlFUmRUU0o3UjVPWTRORW9LblBxcDNFa0JhdnYxZ0pqU3FncWVOWmtucXZTRGJ6VnVfNW1NdzAyVF9Xb1ZHWlEySDV6S0FPNzUtTUhaWGh2WDVzZ3Ffb0kxX0E1VEdkaFY2M0RjSzFLQ3Z6cmlFWW9Zb3RoeUdB?oc=5","date":"2024-10-10","type":"deal","source":"Fierce Biotech","summary":"Ono links with LigaChem to bag preclinical ADC in $700M biobuck deal - Fierce Biotech","headline":"Ono links with LigaChem to bag preclinical ADC in $700M biobuck deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9uMjEwN2RlOWpucVJVOEQzRGhOR1BSaHdzUjh5dTZYd3R5Z01MS3JnMUkwdkgxaVpyNHB2UFNhWUFzc05GZ1RwaVhhQ2ZTTnVtcXJWQThzUlJYbjZvSnpWdkpIbFV0dS1HRGdTaEgzOXd1d0JH?oc=5","date":"2024-10-10","type":"pipeline","source":"Businesskorea","summary":"Ligachem Biosciences Agrees to Transfer ADC Technology to Ono Pharmaceutical - Businesskorea","headline":"Ligachem Biosciences Agrees to Transfer ADC Technology to Ono Pharmaceutical","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":2,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}